Didanosine
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Didanosine contains NLT 98.0% and NMT 102.0% of C10H12N4O3, calculated on the anhydrous basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
B. The retention time of the major peak from the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 Procedure
Buffer: 0.77 g/L of ammonium acetate in water
Mobile phase: Acetonitrile and Buffer (1:21)
Standard solution: 0.1 mg/mL of USP Didanosine RS in water
Sample solution: 0.1 mg/mL of Didanosine in water
[Note—Mix for 1 h to dissolve completely before use.]
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; packing L1
Flow rate: 2 mL/min
Injection size: 20 µL
System suitability
Sample: Standard solution
[Note—The retention time of didanosine is between 7 and 11 min.]
Suitability requirements
Column eciency: NLT 6000 theoretical plates
Tailing factor: NMT 2.5
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of didanosine (C10H12N4O3) in the portion of Didanosine taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of the Sample solution
rs = peak response of the Standard solution
Cs = concentration of the Standard solution (mg/mL)
Cu = concentration of the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on the anhydrous basis
4 IMPURITIES
4.1 Residue on Ignition 〈281〉: NMT 0.2%
Change to read:
4.2 Related Compounds
Buffer: Prepare as directed in the Assay.
Diluent: Adjust the pH of the Buffer with sodium hydroxide to 9. Prepare a mixture of acetonitrile and Buffer (1:19). Solution A: Acetonitrile and Buffer (1:19)
Solution B: Acetonitrile and Buffer (1:3)
System suitability solution: 0.5 mg/mL of (ERR 1-Jun-2019) USP Didanosine System Suitability Mixture RS in Diluent Standard stock solution A: 0.05 mg/mL of USP Didanosine Related Compound A RS in Diluent
Standard stock solution B: 0.025 mg/mL of USP Didanosine RS in Diluent
Standard stock solution C: 0.025 mg/mL of USP Didanosine Related Compound B RS in Diluent
Standard solution: 5 µg/mL of USP Didanosine Related Compound A RS, 1.5 µg/mL of USP Didanosine RS, and 1.5 µg/mL of USP Didanosine Related Compound B RS from a mixture of Standard stock solution A, Standard stock solution B, and Standard stock solution C, respectively, diluted with Diluent
Sample solution: 0.5 mg/mL of Didanosine in Diluent
Mobile phase: See Table 1.
Table 1
Time (min) | Solution A (%) | Solution B (%) |
| 0 | 100 | 0 |
| 15 | 100 | 0 |
| 20 | 0 | 100 |
| 30 | 0 | 100 |
| 35 | 100 | 0 |
| 45 | 100 | 0 |
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 2 mL/min
Injection size: 10 µL
System suitability
Samples: System suitability solution and Standard solution
[Note—Didanosine elutes between 6 and 7.5 min; the relative retention times for didanosine, didanosine related compound A, and didanosine related compound B are 1.0, 0.28, and 2.11, respectively.]
Suitability requirements
Resolution: NLT 3.0 between didanosine and dideoxydidehydroinosine, System suitability solution
Column eciency: NLT 6000 theoretical plates for dideoxydidehydroinosine, System suitability solution Relative standard deviation: NMT 2.0% for didanosine related compound A, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of didanosine related compound A in the portion of Didanosine taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of didanosine related compound A from the Sample solution
rs = peak response of didanosine related compound A from the Standard solution
Cs = concentration of USP Didanosine Related Compound A RS in the Standard solution (mg/mL)
Cu = concentration of didanosine in the Sample solution (mg/mL)
Calculate the percentage of all other impurities in the portion of Didanosine taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of the Sample solution
rs = peak response of the Standard solution
Cs = concentration of USP Didanosine RS in the Standard solution (mg/mL)
Cu = concentration of the Sample solution (mg/mL)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
Didanosine related compound A | 0.28 | 0.5 |
| Inosine | 0.39 | 0.2 |
| 2′-Deoxyinosine | 0.45 | 0.3 |
| 3′-Deoxyinosine | 0.51 | 0.2 |
2′,3'-Anhydroinosine | 0.59 | 0.2 |
| Dideoxydidehydroinosine | 0.81 | 0.2 |
| Didanosine | 1.0 | _ |
Didanosine related compound B | 2.1 | 0.2 |
| 5′-Deoxydideoxyadenosine | 3.1 | 0.2 |
| Any other individual, unidentied impurity | _ | 0.1 |
| Total impurities | _ | 1.0 |
5 SPECIFIC TESTS
5.1 Optical Rotation, Specific Rotation 〈781S〉
Sample solution: 10 mg/mL in water
Acceptance criteria: −28° to −24°, anhydrous
5.2 Water Determination, Method I 〈921〉: NMT 2.0%
6 ADDITIONAL REQUIREMENTS
6.1 Packaging and Storage:
Preserve in well-closed containers, and store at controlled room temperature.
6.2 USP Reference Standards 〈11〉
USP Didanosine RS
USP Didanosine Related Compound A RS
Hypoxanthine.
USP Didanosine Related Compound B RS
2′,3′-Dideoxyadenosine.
USP Didanosine System Suitability Mixture RS

